霉酚酸酯对器官移植受者次黄嘌呤核苷酸脱氢酶活性的影响
被引量：3
摘要
霉酚酸酯（mycophenolate mofetil，MMF）作为一种高特异性的淋巴细胞抑制剂已广泛应用于各种实体器官的移植。MMF经胃肠道吸收入血并迅速水解为活性成分霉酚酸（mycophenolic acid，MPA），大部分MPA和血浆蛋白结合，少量以游离形式发挥免疫抑制作用。
出处
《诊断学理论与实践》
2009年第6期662-664,共3页
Journal of Diagnostics Concepts & Practice
基金
上海自然科学基金项目资助(08ZR1414200)
参考文献30
-
1Port FK, Merion RM, Goodrich NP, et al. Recent trends and results for organ donation and transplantation in the United States, 2005[J]. Am J Transplant, 2006, 6(5 Pt 2): 1095-1100.
-
2Nowak I, Shaw LM. Effect of mycophenolic acid glucuronide on inosine monophosphate dehydrogenase activity [J]. Ther Drug Monit, 1997, 19(3): 358-360.
-
3Picard N, Ratanasavanh D, Premaud A, et al. Identification of the UDP-glucuronosyhransferase isoforms involved in mycophenolic acid phase II metabolism [J]. Drug Metab Dispos, 2005, 33(1): 139-146.
-
4Bowalgaha K, Miners JO. The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomes [J]. Br J Clin Pharmacol, 2001, 52(5): 605-609.
-
5Hood KA, Zarembski DG. Mycophenolate mofetil: a unique immunosuppressive agent [J]. Am J Health Syst Pharm, 1997, 54(3): 285-294.
-
6Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients [J]. Clin Pharmacokinet, 2007, 46(1): 13-58.
-
7Weimert NA, Derotte M, Alloway RR, et al. Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications [J]. Ther Drug Monit, 2007, 29(2): 141-149.
-
8McPhillips CC, Hyle JW, Reines D. Detection of the mycophenolate-inhibited form of IMP dehydrogenase in vivo [J]. Proc Natl Acad Sci U S A, 2004, 101(33): 12171- 12176.
-
9Blaheta RA, Leckel K, Wittig B, et al. Inhibition of endothelial receptor expression and of T-cell ligand aetivity by myeophenolate mofetil[J]. Transpl Immunol, 1998, 6 (4): 251-259.
-
10Natsumeda Y, Ohno S, Kawasaki H, et al. Two distinct cDNAs for human IMP dehydrogenase [J]. J Biol Chem, 1990, 265(9): 5292-5295.
同被引文献19
-
1Chen L, Pankiewicz K W. Recent development of IMP dehydrogenase inhibitors for the treatment of cancer[J]. Curt Opin Drug Discov Devel, 2007, 10 (4): 403-412.
-
2Krzysztof W P. Inhibitors of inosine monophosphate dehydrogenase as potential chemotherapeutic agents[J]. Expert Opin Ther Pat, 2001,11(7): 1161-1170.
-
3Hedstrom L, Gan L. IMP dehydrogenase: structural schizophrenia and an unusual base[J]. Curr Opin Chem Biol, 2006, 10(5): 520-525.
-
4Gilpin M L, Box S J, Elson A L. New quinine antibiotics of the granaticin type,isolated from streptomyces lateritius. II .Strcture determination[J]. JAntibiot, 1988, 41(4): 512-518.
-
5Bentley R. Mycophenolic acid: a one hundred year odyssey from antibiotic to immunosuppressant[J]. Chem Rev, 2000, 100(10): 3801-3826.
-
6Chen L, pankiewicz K W. Recent development of IMP dehydrogenase inhibitors for the treatment of cancer[J]. Curt Opin Drug Discov Devel, 2007, 10(4): 403-412.
-
7Watkins W J, Chen J M, Cho A, et al. Phosphonic acid- containing analogues of mycophenolic acid as inhibitors of IMPDH[J]. BioorgMed Chem Lett, 2006, 16(13): 3479-3483.
-
8林洁,可爱兵,张雪莲,郑智慧,朱京童,路新华,李业英,崔晓兰,石英,张华,贺建功.微生物来源的次黄嘌呤一磷酸盐脱氢酶抑制剂2264 A和B的研究[J].中国抗生素杂志,2008,33(8):463-466. 被引量：4
-
9栗若兰,郑智慧,路新华,张雪霞,董爱华,段宝玲,赵宝华.霉酚酸对人结肠癌SW620细胞凋亡的诱导作用及其机制[J].河北师范大学学报（自然科学版）,2013,37(5):519-523. 被引量：2
-
10于立新,周敏捷,罗敏.肾移植受者应用霉酚酸酯的合理治疗窗[J].南方医科大学学报,2014,34(12):1842-1845. 被引量：7
引证文献3
-
1任晓,路新华,郑智慧,张雪莲,朱京童,范玉玲,丁彦博,蒋沁,段宝玲.次黄嘌呤核苷酸脱氢酶抑制剂N01WB-352A、B的研究[J].中国抗生素杂志,2012,37(5):362-365. 被引量：2
-
2徐冬梅,穆云龙,郭会灿,张丽媛,亢希然,郭英.次黄嘌呤核苷酸脱氢酶抑制剂产生菌的筛选及aquayamycin的结构鉴定[J].中国抗生素杂志,2018,43(12):1482-1487.
-
3王红伟,高宗真,郝娟,李冬冬,孙艳.吗替麦考酚酯致踝关节疼痛1例[J].中国药物应用与监测,2022,19(5):350-352.
二级引证文献2
-
1霍培元,徐岩,林洁,李业英,郑海洲,沈文斌,任晓,石英,崔晓兰,郑智慧,路新华,张雪霞.PTP1B抑制活性真菌F956的鉴定和代谢产物研究[J].中国抗生素杂志,2018,43(1):35-39.
-
2郑胜蓝,李宗显,朱运平.蓝色化合物榴菌素及其类似物的研究现状[J].中国食品学报,2022,22(5):399-411.
-
1张大军,仲兆金,李卓荣.以次黄嘌呤核苷酸脱氢酶为靶点的药物研发[J].中国医药生物技术,2012,7(2):130-135.
-
2王会平,倪江,等.L—酪氨酸等对大鼠黄体细胞3β—羟—甾体脱氢酶活性的影响[J].中国药理通讯,2003,20(1):65-66.
-
3王津生,李学平,冒长峙.新型免疫抑制剂霉酚酸酯在皮肤科的应用前景[J].中华皮肤科杂志,2001,34(1):76-78. 被引量：5
-
4杜勇,李幼姬,孙林.霉酚酸酯治疗狼疮性肾炎[J].国外医学（内科学分册）,1999,26(9):371-373. 被引量：4
-
5余自成,江涛,瞿江媛,田薇薇,马明华,陈红君,陈红专.用HPLC-MS/MS法同时测定Caco-2细胞单层转运介质中吗替麦考酚酯和麦考酚酸的浓度[J].药学服务与研究,2012,12(6):423-426. 被引量：2
-
6茅华荣,张伟霞,顾志冬,陈冰,陈皓.霉酚酸对肝移植受者外周血单核细胞IMPDH活性的影响[J].中国现代应用药学,2010,27(11):1043-1046.
-
7胡金,王辉强,李玉环.以次黄嘌呤核苷酸脱氢酶为靶点的抗病毒药物研究进展[J].中国医药生物技术,2015,10(5):432-437.
-
8任晓,路新华,郑智慧,张雪莲,朱京童,范玉玲,丁彦博,蒋沁,段宝玲.次黄嘌呤核苷酸脱氢酶抑制剂N01WB-352A、B的研究[J].中国抗生素杂志,2012,37(5):362-365. 被引量：2
-
9刘非凡,唐瑛,陈忠庆,唐忠智,王忠强,李军荛,李小平.地塞米松治疗双硫仑样反应的临床和实验研究[J].内科急危重症杂志,2008,14(4):205-206. 被引量：40
-
10穆安娜,黄林清.霉酚酸酯——硫唑嘌呤的首选替代品[J].中国医院用药评价与分析,2002,2(5):300-301. 被引量：1
